Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice

BACKGROUND: To investigate the risk of hepatitis B virus (HBV) reactivation in rheumatoid arthritis (RA) patients with HBV carrier state during treatment of disease-modifying antirheumatic drugs (DMARDs) and the use of antiviral prophylaxis in real-world clinical practice. METHODS: Consecutive RA pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Ying-Qian, Liang, An-Qi, Ma, Jian-Da, Chen, Le-Feng, Zheng, Dong-Hui, Schumacher, H Ralph, Dai, Lie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320507/
https://www.ncbi.nlm.nih.gov/pubmed/25532827
http://dx.doi.org/10.1186/1471-2474-15-449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320507/
https://www.ncbi.nlm.nih.gov/pubmed/25532827
http://dx.doi.org/10.1186/1471-2474-15-449

Ejemplares similares